新確科技(01063.HK)中期淨虧1277.1萬港元 同比收窄47.28%
格隆匯 8 月 27日丨新確科技(01063.HK)公佈,截至2020年6月30日止6個月,公司實現收益9161.1萬港元,同比減少 2.41%; 期間虧損1277.1萬港元,同比收窄47.28%;基本每股虧損1.68港仙。無派息。
截至2020年6月30日止6個月,集團收益 減少約2.4%。就集團總收益而言,約40.6%由企業對企業跨境電子商務業務貢獻,約28.7%來自銷售電話及相關產品、約19.4%來自二手電腦相關組件處理及貿易、約11.2%來自放債業務賺取利息收入及約0.1%來自證劵經紀、配售及包銷業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.